Home > Boards > US Listed > Medical - Drugs > AcelRx Pharmaceuticals, Inc. (ACRX)

ACRX is still a binary bet that mgmt

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Bobwins Member Profile
Member Level 
Followed By 530
Posts 17,269
Boards Moderated 42
Alias Born 10/21/03
160x600 placeholder
Dr. TJ Gan to Present at the 2019 Annual Meeting of the American Society of Anesthesiologists PR Newswire (US) - 10/16/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2019 4:06:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 4:52:50 PM
AcelRx Pharmaceuticals Selected to Present at the 2019 Military Health System Research Symposium PR Newswire (US) - 8/15/2019 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 6:04:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 4:11:11 PM
AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire (US) - 8/5/2019 4:05:00 PM
AcelRx to announce second quarter 2019 results and provide an update on the company's business on Monday, August 5th, 2019 PR Newswire (US) - 8/2/2019 10:12:00 AM
AcelRx added to the Russell 2000® and 3000® indexes PR Newswire (US) - 7/1/2019 2:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:06:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:05:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:01:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:59:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 4:50:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 6:06:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 7:11:14 AM
AcelRx announces the closing of a $25 million senior secured debt facility PR Newswire (US) - 6/3/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/14/2019 6:11:56 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/14/2019 6:11:08 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/9/2019 8:56:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:53:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:06:39 PM
AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/8/2019 4:01:00 PM
Bobwins Member Level  Thursday, 05/09/19 01:57:04 PM
Re: ThatBobGuy post# 1143
Post # of 1179 
ACRX is still a binary bet that mgmt can get industry acceptance of Dsuvia. Obviously the market expected/hoped for a miracle amt of revs to show up in Q1 after 19 whole days for the company to sign up health insurance plans, hospitals and get doctors to prescribe a new drug.

We don't know if ACRX will succeed. That uncertainty led to a selloff today after ACRX showed a small amt of revs in Q1.

Investors have to review and decide for themselves if mgmt will succeed over the long run. The sellers today don't have any special abilities. They don't know if ACRX will succeed next month or next year. They could be right or lose out on a big winner.

It's too early to tell.

Investors have to review the available info and decide for themselves. What happens today or tomorrow with the stock price won't matter. What happens with the sales reps matters.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist